NFKB2 and central nervous system cancer: To further examine the transcriptional activities driven by TWEAK-induced p52 activation in gliomas, we performed ChIP-seq using RNA polymerase II (RNA Pol II) antibody in U-87 MG cells treated with and without TWEAK.